Equities Research Analysts’ New Coverage for October, 30th (ADMA, CYAD, ESTC, GFF, IRDM, PRTO, UNFI, VTR)

Share on StockTwits

Equities Research Analysts’ new coverage for Tuesday, October 30th:

HC Wainwright started coverage on shares of ADMA Biologics (NASDAQ:ADMA). They issued a buy rating and a $17.00 price target on the stock.

William Blair assumed coverage on shares of CELYAD SA/ADR (NASDAQ:CYAD). The firm issued a buy rating on the stock. The analysts wrote, “Celyad S.A. Using the Body’s “Natural Born Killers” in Solid and Liquid Tumors; Initiating With an Outperform Rating We are initiating coverage on Celyad with an Outperform rating and $53 fair value estimate.””

Jefferies Financial Group Inc started coverage on shares of Elastic (NYSE:ESTC). They issued a hold rating on the stock.

Goldman Sachs Group Inc assumed coverage on shares of Elastic (NYSE:ESTC). The firm issued a buy rating on the stock.

Barclays PLC assumed coverage on shares of Elastic (NYSE:ESTC). The firm issued an overweight rating on the stock.

JPMorgan Chase & Co. started coverage on shares of Elastic (NYSE:ESTC). They issued a neutral rating on the stock.

JPMorgan Chase & Co. began coverage on shares of Griffon (NYSE:GFF). JPMorgan Chase & Co. issued an underweight rating on the stock.

Barclays PLC initiated coverage on shares of Iridium Communications (NASDAQ:IRDM). They issued a buy rating and a $26.00 price target on the stock.

Maxim Group started coverage on shares of Proteon Therapeutics (NASDAQ:PRTO). They issued a buy rating and a $5.00 target price on the stock.

Goldman Sachs Group Inc assumed coverage on shares of United Natural Foods (NASDAQ:UNFI). Goldman Sachs Group Inc issued a sell rating on the stock.

JPMorgan Chase & Co. began coverage on shares of Ventas (NYSE:VTR). The firm issued a neutral rating on the stock.

Receive News & Ratings for ADMA Biologics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADMA Biologics Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply